Clinical Trial

A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, non-randomized, open-label, single-dose clinical PK study in healthy postmenopausal female participants.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-05-08
notable Enrollment reduced: 8 -> 6 participants 2026-05-08
Trial Details
NCT Number NCT07537231
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Healthy Postmenopausal Women, Absorption, Metabolism, Excretion
Enrollment 6 participants
Start Date 2026-04-09
Primary Completion 2026-04-18 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-07